Ritter Pharmaceuticals Companies
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Last Funding Date:
2015
Industry:
Healthcare InsurTech
Investment Stage:
N/A
Technology:
Anti-infective Drugs
Number Of Exists:
N/A
Investor Type:
N/A
Total Funding:
25730038
Founded Date:
2004-01-01
Headquarters:
Greater Los Angeles Area, West Coast, Western US